EMVision Medical Devices Ltd (ASX:EMV)
1.760
+0.020 (1.15%)
Apr 28, 2026, 4:10 PM AEST
EMVision Medical Devices Market Cap
EMVision Medical Devices has a market cap or net worth of 161.71 million as of April 28, 2026. Its market cap has increased by 5.06% in one year.
Market Cap
161.71M
Enterprise Value
147.65M
Revenue
5.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.76
Market Cap Chart
Since December 13, 2018, EMVision Medical Devices's market cap has increased from 17.56M to 161.71M, an increase of 820.84%. That is a compound annual growth rate of 35.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 161.71M | -2.25% |
| Dec 31, 2025 | 165.43M | 2.08% |
| Dec 31, 2024 | 162.05M | 22.64% |
| Dec 29, 2023 | 132.14M | -8.06% |
| Dec 30, 2022 | 143.72M | -30.65% |
| Dec 31, 2021 | 207.25M | -6.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anteris Technologies Global | 739.23M |
| PolyNovo | 694.30M |
| Aroa Biosurgery | 183.33M |
| Lumos Diagnostics Holdings | 152.24M |
| SomnoMed | 136.93M |
| Epiminder | 129.81M |
| Cleo Diagnostics | 93.07M |
| Compumedics | 56.93M |